Important issues at heart: cardiovascular risk management in rheumatoid arthritis.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2013, v. 5, n. 4, p. 163, doi. 10.1177/1759720X13491853
- By:
- Publication type:
- Article
Works matching IS 1759720X AND DT 2013 AND VI 5 AND IP 4
Results: 6
1
2
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2013, v. 5, n. 4, p. 166, doi. 10.1177/1759720X13491025
- By:
- Publication type:
- Article
3
Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2013, v. 5, n. 4, p. 199, doi. 10.1177/1759720X13490860
- By:
- Publication type:
- Article
4
Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2013, v. 5, n. 4, p. 182, doi. 10.1177/1759720X13485829
- By:
- Publication type:
- Article
5
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2013, v. 5, n. 4, p. 210, doi. 10.1177/1759720X13485503
- By:
- Publication type:
- Article
6
Latest advances in connective tissue disorders.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2013, v. 5, n. 4, p. 234, doi. 10.1177/1759720X13480280
- By:
- Publication type:
- Article